We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




AI Chest CT Analysis Distinguishes COVID-19 from Pneumonia

By HospiMedica International staff writers
Posted on 31 Mar 2020
An artificial intelligence (AI) deep learning model can accurately detect COVID-19 and differentiate it from community acquired pneumonia (CAP) and other lung diseases, according to a new study.

Researchers at Wuhan Huangpi People's Hospital (China), Shenzhen University Health Science Center (Shenzhen, China), and other institutions conducted a multicenter, retrospective study to develop the COVID-19 detection neural network (COVNet), a fully automatic AI framework that extracts visual features from volumetric chest CT exams for the detection of COVID-19, and differentiates them from CAP and other lung findings. More...
Datasets were collected from six hospitals and diagnostic performance was assessed and evaluated.

In all, the collected dataset consisted of 4,356 volumetric chest CT exams from 3,322 patients (average age 49 years, 55% male). Overall per-exam sensitivity and specificity for detecting COVID-19 in the independent test set was 90% and 96%, respectively. The researchers also showed that the per-exam sensitivity and specificity for detecting CAP was 87% and 92%, respectively. The study was published on March 19, 2020, in Radiology.

“We were able to collect a large number of CT exams from multiple hospitals, which included 1,296 COVID-19 CT exams,” concluded lead author Lin Li, MD, of the Wuhan Huangpi People's Hospital department of radiology. “More importantly, 1,735 CAP and 1,325 non-pneumonia CT exams were also collected as the control groups in this study in order to ensure the detection robustness, considering that certain similar imaging features may be observed in COVID-19 and other types of lung diseases.”

The coronavirus Disease 2019 (COVID-19) outbreak has rapidly spread all over the world. On January 30, 2020, it was declared as a public health emergency of international concern by the World Health Organization (WHO). It is typically confirmed by reverse-transcription polymerase chain reaction (PCR), but CT can detect certain characteristic manifestations in the lung associated with COVID-19, such as bilateral ground-glass, consolidative pulmonary opacities on CT, and a crazy-paving pattern, among others.

Related Links:
Shenzhen University Health Science Center


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Spirometry & Oximetry Software
MIR Spiro
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.